10 Micro Cap Stocks That Will Skyrocket

Page 9 of 9

1. Pacific Biosciences of California, Inc. (NASDAQ:PACB)

Number of Hedge Fund Investors  in Q1 2024: 27

Date of Newsletter: April 11th VERIF

This stock is an “era-defining technology” that could disrupt the “entire AI market.” Quite a tall claim and its ad backs it up by adding that the technology could reach 2 billion users in just three years. An “earlier stage investment where truly life-changing profits can still be made,” and not only can its hardware “process a person’s entire DNA genome” but also process DNA at 400 TIMES the speed of the previous technology.”

This stock appears to be something special especially since 2024 has been the year for gene editing technologies. This stock is Pacific Biosciences of California, Inc. (NASDAQ:PACB). It is a California based gene sequencing systems provider. Gumshoe points out that its shares have lost more than half their value since January and attributes the drop to a tough market dominated by giants. It is appreciative of Pacific Biosciences of California, Inc. (NASDAQ:PACB)’s 100%+ revenue growth in 2023, even though it was powered by sales of new equipment whose high costs impacted gross and operating margins. Analysts expect 20% revenue growth in 2024, and one fund that’s bought it is Cathie Wood’s Ark Investment. As of July 2024, it held a $45 million stake in the firm according to Insider Monkey’s data.

PACB leads the micro cap newsletter stock picks of hedge funds. But our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than PACB but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: Analyst Sees a New $25 Billion “Opportunity” for NVIDIA and 10 Best of Breed Stocks to Buy For The Third Quarter of 2024 According to Bank of America.

Disclosure: None.

Page 9 of 9